The inhibition of EGFR and NFκB signaling protects from LPS-induced ALI by significantly suppressing inflammatory responses and weakening alveolar, as well as vascular, permeability [47,48,49]. This evidence concerns the gene NFKB1 and acute respiratory distress syndrome.